...
首页> 外文期刊>Food & Function >(-)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling
【24h】

(-)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling

机译:( - ) - EPICATECHIN和结肠代谢物2,3-二羟基苯甲酸通过NOX-4 / P38信号传导来保护肾近端管状细胞的高葡萄糖和脂多糖诱导的炎症

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA) and 3-hydroxyphenylpropionic acid (HPPA), have been suggested to exert beneficial effects in diabetes. This study was aimed at investigating whether the mentioned compounds could prevent inflammation in renal proximal tubular NRK-52E cells induced by high glucose and lipopolysaccharide (LPS). Pre-treatment of cells with EC and DHBA (5 mu M) reverted the enhanced levels of pro-inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), activated by high glucose and LPS. Additionally, EC and DHBA pre-incubation reduced the increased values of adhesion molecules, namely, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), as well as those of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated kinase (ERK), -c-jun N-terminal kinase (JNK) and -p38 protein kinase (p38)] activated by the high glucose and LPS challenge. Thus, in EC and DHBA pre-treated cells ICAM-1, p-ERK and p-JNK were returned to control values, and VCAM-1 and p-p38 levels were reduced by similar to 20 and 25%, respectively, when compared to high glucose plus LPS-stimulated cells. Likewise, pre-treatment with EC and DHBA protected against high glucose plus LPS-triggered oxidative stress by preventing increased ROS and NADPH oxidase 4 (NOX-4) levels (similar to 25 and 45% reduction, respectively). By using specific inhibitors of p38 and NOX-4, the participation of both proteins in EC- and DHBA-mediated protection against inflammation and associated oxidative stress was shown. Taken together, EC and DHBA exert beneficial effects in renal proximal tubular cells, as they contribute to preventing the inflammatory-induced milieu and the accompanying redox imbalance, playing NOX-4/p38 a crucial role.
机译:糖尿病中存在慢性高血糖和炎症,两种过程都与糖尿病肾病的发病机制有关。已经提出了从类黄酮摄入(如2,3-二羟基苯甲酸(DHBA),3,4-二羟基苯甲酸(DHPAA)和3-羟基苯基丙酸(HPPA)的主要结肠酚酸和主要结肠酚酸和主要的结肠​​酚酸(如2,3-二羟基苯甲酸(DHPAA)和3-羟基苯基丙酸(HPPA)。糖尿病的影响。本研究旨在研究上述化合物是否可以防止由高葡萄糖和脂多糖(LPS)诱导的肾近端管状NRK-52E细胞中的炎症。用EC和DHBA(5μm)对细胞的预处理恢复了促炎细胞因子的增强水平,例如肿瘤坏死因子-α(TNF-α),白细胞介素-6(IL-6)和单核细胞化学抑制剂蛋白1 (MCP-1),由高葡萄糖和LPS激活。另外,EC和DHBA预孵育降低了粘附分子的增加值,即细胞间细胞粘附分子-1(ICAM-1)和血管细胞粘附分子-1(VCAM-1)以及丝裂剂激活的通过高葡萄糖和LPS挑战,蛋白激酶(MAPKS)[细胞外信号调节激酶(ERK),-C-JUN N-末端激酶(JNK)和-P38蛋白激酶(P38)]。因此,在EC和DHBA预处理的细胞中,ICAM-1,P-ERK和P-JNK返回控制值,并且在比较时,VCAM-1和P-P38水平分别减少到20和25%高葡萄糖加上LPS刺激的细胞。同样地,通过防止增加的ROS和NADPH氧化酶4(NOX-4)水平增加(分别减少25%和45%),用EC和DHBA预处理抗EC和DHBA免受高葡萄糖加上LPS引发的氧化应激。通过使用P38和NOX-4的特异性抑制剂,显示了两种蛋白质在EC和DHBA介导的免受炎症和相关氧化应激的保护中的参与。在一起,EC和DHBA在肾近端管状细胞中施加有益效果,因为它们有助于预防炎症诱导的Milieu和随附的氧化还原性失衡,演奏NOX-4 / P38至关重要的作用。

著录项

  • 来源
    《Food & Function》 |2020年第10期|共14页
  • 作者单位

    CSIC Dept Metab &

    Nutr Inst Food Sci &

    Technol &

    Nutr ICTAN Jose Antonio Novais 10 Ciudad Univ Madrid 28040 Spain;

    Univ Complutense Madrid UCM Fac Farm Secc Dept Fisiol Madrid Spain;

    CSIC Dept Metab &

    Nutr Inst Food Sci &

    Technol &

    Nutr ICTAN Jose Antonio Novais 10 Ciudad Univ Madrid 28040 Spain;

    CSIC Dept Metab &

    Nutr Inst Food Sci &

    Technol &

    Nutr ICTAN Jose Antonio Novais 10 Ciudad Univ Madrid 28040 Spain;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 食品工业;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号